Skip to content
Screener

Bruker BRKR Operating Cash Flow

Operating Cash Flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$2.13B+51.9%
Danaher logo
DanaherDHR
$1.53B+14.6%
TEC
Bio-TechneTECH
$86.66M+111%
WAT
Waters CorporationWAT
$200M+391%
Agilent Technologies logo
Agilent TechnologiesA
$277M+25.3%
908 Devices logo
908 DevicesMASS
$1.21M+108%

Other financials

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Operating income-$65.3M-649%
Net income-$52.0M-784%
EPS (diluted)-$0.41-920%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation

See full
Market cap$7.99B+71.7%
Enterprise value$9.62B+37.7%
P/S2.3×+0.9×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
Net margin-0.6%-10.0pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Bruker’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:24 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335226
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Inventories(70.9)(56.8)
Income taxes payable, net(46.3)(105.3)
Other changes in operating assets and liabilities, net(23.9)47.1
Net cash used in operating activities(6.2)(62.5)
Cash flows from investing activities:
Purchases of property, plant and equipment and intangible assets(53.0)(47.3)
Cash paid for acquisitions, net of cash acquired(16.0)(69.5)
Other investing activities, net4.0(0.4)

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Bruker's operating cash flow?
Bruker (BRKR) reported operating cash flow of -$77.4M in Q2 2026.
How has Bruker's operating cash flow changed year-over-year?
Bruker's operating cash flow increased by 39.3% year-over-year, from -$127.5M to -$77.4M.
What is the long-term trend for Bruker's operating cash flow?
Over 3 years (2021 to 2025), Bruker's operating cash flow has grown at a -22.0% compound annual growth rate (CAGR), from $282.4M to $134.1M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Bruker's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude